Transformational cell therapies for patients with pancreatic disease

Robert Clisdell

Robert Clisdell

Non-Executive Director

Mr. Clisdell is based in Sydney and is a non-executive director of Keytone Dairy Corporation (ASK:KTD), DroneShield (ASX:DRO) and UUV Aquabotix Limited (ASX:UUV) and the head of Bergen Capital (Australia), LLC’s Australian office. Prior to Bergen, Mr. Clisdell gained over 15 years’ experience in the banking, finance and accounting sectors in the Australian market as an investment banker at Credit Suisse and Caliburn Partnership (now Greenhill & Co.) and worked in equity capital markets at Ord Minnett.

Mr. Clisdell began his career at Ernst & Young where he qualified as a Chartered Accountant. Mr. Clisdell has a Bachelor of Commerce degree from the University of Sydney (majoring in Finance & Accounting) and a Graduate Diploma in Applied Finance & Investment from FINSIA.

Kyslecel personalized cell therapy for chronic pancreatitis. Because pain should not define your life.